Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.
about
Maspin (SERPINB5) is an obligate intracellular serpinThe role of proteomics in defining the human embryonic secretomeIQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cellsDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxMapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3Integrative analysis to select cancer candidate biomarkers to targeted validation.Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/ConneImmunoscreening of the extracellular proteome of colorectal cancer cells.Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomesHigh-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.Discovery of pathway biomarkers from coupled proteomics and systems biology methodsAminopeptidase activities as prospective urinary biomarkers for bladder cancer.Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics.Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signalingCandidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.Oxidative protein folding and the Quiescin-sulfhydryl oxidase family of flavoproteins.Selective assembly of DNA-conjugated single-walled carbon nanotubes from the vascular secretome.Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryProteomic studies in breast cancer (Review).SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy.Quantitative organelle proteomics of MCF-7 breast cancer cells reveals multiple subcellular locations for proteins in cellular functional processes.Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.Identification of annexin II as a novel secretory biomarker for breast cancer.Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer.Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?Secretome identification of immune cell factors mediating metastatic cell homing.Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.Advances in the proteomic investigation of the cell secretome.Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
P2860
Q24634632-9BCB03DD-5507-4752-9B39-DAB372D538BAQ24646212-3FA79865-0D76-43C7-9F66-D18BE0FF70D6Q28256129-7F70AB84-0A32-4FB3-8EA2-CC0471DA9272Q28477021-B2A3A569-A986-4FDA-ACC9-6BB983E7DBB6Q28678685-B487EBC0-80F8-4041-8EE8-266E90DE10BFQ30278389-FD814CEB-B7BA-48AB-AEBE-890FFC3697BEQ33301092-F2D300F2-6BB2-4BB1-8A2B-6D8D2DBE5A8FQ33534464-A3389D7C-919E-432C-9517-D6D186162622Q33570732-85A365BE-41A8-4847-94F8-801B3FB5B818Q33579375-4DDDC677-1707-43D4-AE18-375E31FA943BQ33628868-144EE295-E51D-45E7-B729-70A678F29EDDQ33737009-DC9A115A-6B56-43AF-92D5-800A61E4D82CQ33762931-6202B96A-099E-41C3-A476-A523837BC6D1Q33796825-1ED07AE0-7FAD-410A-96A3-B17D95624CADQ33812900-10340107-3336-4E3C-8A6F-3DA3AE060176Q33837120-3983A7C2-E478-4FBA-97AF-6FDCB8260E09Q33865519-5BF417BC-8288-4EF2-871C-0CD0512E207CQ33883005-4230F75F-46ED-464C-9E51-CD9729063292Q33955266-1B100E75-DABD-4DCF-B6C4-C1A01B8E5609Q34222636-B2133BDC-6480-4DDA-B07B-89065AC5389BQ34239172-1FDFB79E-3FDF-411B-9576-FB389F6FD64DQ34239193-A340ED22-8F4B-42A3-9719-609525F6C60EQ34319634-4C666D59-0269-406F-AABC-169E40418B74Q34410598-D96359B4-AFC8-4A67-BEEB-CCB8768447B8Q34608490-D663B9A7-A03E-43E8-B894-921357F04B4BQ34645702-D63EF60D-6755-4F22-9703-CA91092C6DA8Q34667726-CA54820D-68B9-4226-AE23-9CB7375FAF1CQ34757824-8F9FBB1F-5CB2-443B-BF80-72782BE891E0Q34982525-52479570-50A7-4E19-9412-4005B74F5C89Q35026909-C12334AD-D01C-43BF-821E-ACDD69492F67Q35154283-5861B3B8-8FE8-47F9-BA5B-87E3EE1DFCBCQ35497551-D554DF66-F6FD-4D76-9C7D-7E7FFAE9B092Q35793752-D394E691-047F-4EC3-9FB0-11CFDF3A29B2Q35987073-A45A0D51-A705-49DF-8DB6-35128894CF63Q36040355-C56069B1-7409-4538-BEF7-92F0570DC791Q36117893-010D446D-8EDA-42C6-BFA0-4FF5E430411BQ36346184-0C3A8FFE-4307-4C1E-9F07-8BFA78464731Q36386860-594C1E2A-C492-4E2A-B811-B1C554F97EFAQ36406560-A4564244-43EF-407F-8819-FFB20D1683CFQ36464876-4D9FB775-E0CD-471E-B2A9-AA4365182EAB
P2860
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proteomics analysis of conditi ...... rkers and therapeutic targets.
@en
type
label
Proteomics analysis of conditi ...... rkers and therapeutic targets.
@en
prefLabel
Proteomics analysis of conditi ...... rkers and therapeutic targets.
@en
P2860
P1476
Proteomics analysis of conditi ...... rkers and therapeutic targets.
@en
P2860
P304
P356
10.1074/MCP.M600465-MCP200
P577
2007-07-25T00:00:00Z